Media Partner

Athens, Greece
01-03 December 2022
39 Professionals

Welcome Address

Dear Friends and Colleagues,

It is a great pleasure to welcome you to the “8th Symposium “Advances in Cancer Immunology & Immunotherapy” in the city of Athens, Greece.

The 8th Symposium “Advances in Cancer Immunology & Immunotherapy” is an intensive, three days interactive meeting during which invited speakers will address the current and accumulated knowledge of basic immuno-biology and translational cancer research, as well as therapeutic developments in the field of cancer immunotherapy according to the newest clinical trials.

The scientific objectives of the 8th Symposium “Advances in Cancer Immunology and Immunotherapy” are focused on the: (a) predictive and prognostic biomarkers for immunotherapy (b) mechanisms of action of different immunotherapeutic treatments (c) the efficacy and safety data of cancer immunotherapy regimens; and (d) strategies for immunomodulation, counteracting resistance and mitigating adverse events.

This year’s Symposium will feature world-renowned oncologists and researchers who will provide their insights on the above mentioned  topics in an effort to better understand tumor evolution and designing improved treatment strategies.

The 8th Symposium “Advances in Cancer Immunology and Immunotherapy” welcome the participation of scientists, clinicians, students and health care professionals interested in the field of Cancer Immunology and Immunotherapy.

We would like to thank you for your participation and we are looking forward to seeing you in Athens.

Warm regards,

The Organizing Committee

Athanasios Kotsakis

MD, PhD, Professor of Medical Oncology, School of Medicine, University of Thessaly, Larissa , Greece

Ourania Tsitsilonis

MD, PhD, Professor of Immunology, Department of Biology, National and Kapodistrian University of Athens, Greece

Constantin N. Baxevanis

Scientific Director, Cancer Immunology and Immunotherapy Center “St.Savvas” Cancer Hospital, Athens, Greece

Graham Pawelec

Professor of Experimental Immunology, Center of Medical Research, Department of Immunology, University of Tuebingen, Germany

Monica Neagu

Head of Immunology Department, “Victor Babes” National Institute of Pathology, Bucharest, Romania President of the Romanian Immunology Society, Romania

Suzanne Ostrand-Rosenberg

Adjunct Professor of Pathology Huntsman Cancer Institute (HCL),
University of Utah, USA

Jörg Wischhusen 

Professor of Experimental Tumor Immunology University of Würzburg School of Medicine Department of Gynecology and Obstetrics, Germany

Event's Confirmed Speakers

Gosse Adema, NL
Vincenzo Bronte, ΙΤ
Marianna Christodoulou, CY
Pierre Coulie, BE
Alexandra Drakaki, USΑ
Teresa Frisan, SE
Lorenzo Galluzzi, USΑ
Petros Grivas, USΑ
Ulrich Keilholz, DE
Else Marit Inderberg, NO
Sofia Karagiannis, UK
Greg Kirchenbaum, USA
Michael Koukourakis, GR
Alejandro Madrigal, UK
Dimitris Mastellos, GR
Alexios Matikas, SE
Gilles Maradon
, FR

Noel de Miranda, ES
Monica Neagu, RO
Daniel Öhlund, SE
Patrick Ott, USA
Dionysios Papadatos – Pastos, UK
Annette Paschen, DE
Ioannis S. Pateras, GR
Graham Pawelec, DE
Hans – Georg Rammensee, DE
Christoph Reinhardt, DE
Suzanne Ostrand – Rosenberg, USA
Barbara Seliger, DE
Ferdinandos Skoulidis, USA
Viktor Umansky, DE
Panayiotis Verginis, GR
Teresa Whiteside, USA
Jörg Wischhusen, DE

Media Partner

Event Sessions

Session 1: Tumor Immunity and Immunomodulation

Session 2: Cancer Vaccines

Session 3: Skin Neoplasms and Head and Neck Cancer –  Current Status of Immunotherapy and Future Perspectives 

Session 4: Cancer Biomarkers and Advances in Cancer Treatments

Session 5: Advances in Anti-cancer Immunotherapeutic Approaches

Session 6: Gynecological Cancers and Breast Cancer – Current Status of Immunotherapy and Future perspectives

Session 7: Urinary Tract Neoplasms: Current Challenges and Future Perspectives


Session 8: Intrinsic Regulation of Antitumor Immune Responses

Session 9: Extrinsic Regulation of Antitumor Immune Responses

Session 10: Immunotherapy in Lung Cancer: Current Challenges and Future Perspectives

Session 11: Cancer Immunotherapy in 2022 and a look ahead

Event's Abstract Submission

The Scientific Committee welcomes the submission of abstracts to the 8th Symposium on Advances in Cancer Immunology & Immunotherapy. Abstracts must be submitted in English through this website. Abstracts will be selected on scientific merit. An individual can submit one or more abstracts as presenter or first author. Abstract submission will open from May 16th 2022.

Participate Symposium Online

Our Sponsors

Under the Auspices of

The Hotel

Divani Palace Acropolis

Contact Us